Statements, 2013

Pneumonia accounts for 25% of deaths of children under five in Afghanistan each year.

Following the death of Nelson Mandela, Dagfinn Høybråten, Chair of the GAVI Alliance Board, and Dr Seth Berkley, CEO of the GAVI Alliance, issued statements

Former director of ONE Campaign’s Paris office joins GAVI Alliance.

Mass preventive campaign will protect close to 60 million children and adults.

German support set to benefit East African Community and help improve supply chain.

Senegalese children to benefit from pneumococcal and measles-rubella vaccines .

Commitment to transparency and data quality recognised.

More than four million children will receive the measles-rubella vaccine over the next three months.

Chinese vaccine industry enters world stage with WHO prequalified Japanese encephalitis vaccine

GAVI welcomes Canada’s US$ 20 million pledge to accelerate access to measles vaccines.

Latest data published by Glaxosmithkline and PATH Malaria Vaccine Initiative

In response to a press release issued by Medecins Sans Frontieres (MSF) on 8 August 2013, the GAVI Alliance issued the following statement

The price the GAVI Alliance pays for lifesaving pneumococcal vaccines for children in the world’s poorest countries is set to be reduced under new agreements between GAVI, UNICEF, The World Bank, GlaxoSmithKline and Pfizer.

Results of Hib Initiative supplement published showing new evidence on the impact of Hib vaccines

The UK Department for International Development (DFID) confirms that the GAVI Alliance remains a highly effective organisation that is making progress on areas for improvement highlighted by the UK.

The GAVI Alliance Board asks for in-depth analysis to inform its decisions on the future of GAVI’s vaccines portfolio and requests the GAVI Secretariat to develop a long-term strategy on how GAVI will support the introduction of Inactivated Polio Vaccine in partner countries.

Statement from Dr Seth Berkley, CEO of the GAVI Alliance, following the publication of the report of the UN High Level Panel of Eminent Persons on the Post-2015 Development Agenda.

The largest and most comprehensive study of childhood diarrhoea has confirmed rotavirus as the single biggest cause of diarrhoea-related death and illness in developing countries. This latest evidence suggests that a large number of children are dying from this vaccine-preventable pathogen, and supports the decision by the GAVI Alliance to prioritise rotavirus vaccines.

In response to statements issued by Medecins Sans Frontieres, the GAVI Alliance has issued the following statement.

Pneumonia and diarrhoea together account for nearly one-third of all under-five child deaths in developing countries. Evidence shows that children are dying from these preventable diseases because effective interventions are not reaching them or not provided equitably across all communities.

GAVI’s Transparency & Accountability Policy Team (TAP) has finalised its Audit of Health Systems Strengthening (HSS) in Sierra Leone and the findings have been officially communicated to the Government.

International Women's Day 2013 marks the beginning of a dramatic shift in the health of women and girls. Starting this year, GAVI is supporting the poorest countries of the world to roll out two vaccines that will directly benefit women and girls: human papillomavirus (HPV) against cervical cancer and rubella against 'German measles'.

The GAVI Alliance has been requested by Ms Zainab Hawa Bangura, a former Minister of Health of Sierra Leone, to clarify certain details of its on-going review of GAVI Health Systems Strengthening (HSS) funding support to Sierra Leone.

The GAVI Alliance joins the World Health Organization (WHO), UNICEF and the Government of Nigeria in condemning attacks in Nigeria which have killed and injured health workers.

The GAVI Alliance appoints Simon Lamb as Managing Director of Internal Audit. He succeeds Cees Klumper who has joined the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Delegates at the United Nations Environment Programme recognise the safety of thiomersal – a mercury-based vaccine preservative – and the critical role it plays in global health - by excluding it from a treaty on the release of mercury into the environment.